BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3014478)

  • 1. Production and quality control of the Oka-strain live varicella vaccine.
    D'Hondt E; Berge E; Colinet G; Duchene M; Peetermans J
    Postgrad Med J; 1985; 61 Suppl 4():53-6. PubMed ID: 3014478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worldwide experience with the Oka-strain live varicella vaccine.
    Andre FE
    Postgrad Med J; 1985; 61 Suppl 4():113-20. PubMed ID: 3014468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotyping of different varicella vaccine strains.
    Sauerbrei A; Zell R; Harder M; Wutzler P
    J Clin Virol; 2006 Oct; 37(2):109-17. PubMed ID: 16905356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Live varicella vaccine in severely immunodepressed children.
    Ninane J; Latinne D; Heremans-Bracke MT; De Bruyere M; Cornu G
    Postgrad Med J; 1985; 61 Suppl 4():97-102. PubMed ID: 3014486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of children with malignant diseases with the Oka-strain varicella vaccine.
    Austgulen R
    Postgrad Med J; 1985; 61 Suppl 4():93-5. PubMed ID: 3014485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A live varicella vaccine (Oka strain). Papers presented at the International Workshop on Live Varicella Vaccine. Osaka, Japan, November 14, 1983.
    Biken J; 1984 Sep; 27(2-3):31-141. PubMed ID: 6100053
    [No Abstract]   [Full Text] [Related]  

  • 7. Summary of clinical studies with the Oka live varicella vaccine produced by Smith Kline-RIT.
    André FE
    Biken J; 1984 Sep; 27(2-3):89-98. PubMed ID: 6100065
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunization of acute leukemic children with a live varicella vaccine (Oka strain).
    Kamiya H; Kato T; Isaji M; Torigoe S; Oitani K; Ito M; Ihara T; Sakurai M; Takahashi M
    Biken J; 1984 Sep; 27(2-3):99-102. PubMed ID: 6100066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract]   [Full Text] [Related]  

  • 10. Development and characterization of a live varicella vaccine (Oka strain).
    Takahashi M
    Biken J; 1984 Sep; 27(2-3):31-6. PubMed ID: 6100054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka).
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):123-8. PubMed ID: 6100049
    [No Abstract]   [Full Text] [Related]  

  • 12. Vaccination of children with malignant disease against varicella.
    Slørdahl SH; Wiger D; Strømøy T; Degre M; Thørsby E; Lie SO
    Postgrad Med J; 1985; 61 Suppl 4():85-92. PubMed ID: 3014484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical application of a live varicella vaccine (Oka strain) in a hospital.
    Naganuma Y; Osawa S; Takahashi R
    Biken J; 1984 Sep; 27(2-3):59-61. PubMed ID: 6100059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella vaccine: case studies.
    Takahashi M; Asano Y; Kamiya H; Baba K
    Microbiol Sci; 1985 Aug; 2(8):249-54. PubMed ID: 2856380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of live attenuated varicella vaccine.
    Gershon AA
    Proc Assoc Am Physicians; 1995 Oct; 107(3):365-8. PubMed ID: 8608424
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical trial of the Oka strain of live attenuated varicella vaccine on healthy children.
    Ozaki T; Matsui T; Ichikawa T; Asano Y; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):39-42. PubMed ID: 6100056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of the Varilrix varicella vaccine.
    Chiu SS; Lau YL
    Expert Rev Vaccines; 2005 Oct; 4(5):629-43. PubMed ID: 16221065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year follow-up study of recipients of live varicella vaccine using enhanced neutralization and fluorescent antibody membrane antigen assays.
    Asano Y; Albrecht P; Vujcic LK; Quinnan GV; Kawakami K; Takahashi M
    Pediatrics; 1983 Sep; 72(3):291-4. PubMed ID: 6310478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical trial of live attenuated varicella vaccine (Biken) in children with malignant diseases.
    Konno T; Yamaguchi Y; Minegishi M; Goto Y; Tsuchiya S
    Biken J; 1984 Sep; 27(2-3):73-5. PubMed ID: 6100062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of postexposure immunization with live attenuated varicella vaccine in the household setting--a pilot study.
    Mor M; Harel L; Kahan E; Amir J
    Vaccine; 2004 Dec; 23(3):325-8. PubMed ID: 15530676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.